Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer
- PMID: 28188757
- DOI: 10.1016/j.urology.2016.12.060
Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer
Abstract
Objective: To evaluate the prostate cancer effects of androgen deprivation therapy (ADT) by using a systematic set of methods to calculate specific cognitive functions in men with locally advanced or metastatic prostate cancer.
Materials and methods: From April 2014 to February 2016, a prospective, comparative study was done to evaluate the cognitive effects of hormone therapy. Group 1 consisted of 78 patients with locally advanced or metastatic prostate cancer who received complete ADT treatment continuously for 12 months and group 2 (control group) consisted of 78 patients who underwent radical prostatectomy without any additional treatment. The Montreal Cognitive Assessment (MoCA) test and the Frontal Assessment Battery (FAB) test with Turkish language version were used to evaluate multiple domains of cognitive function.
Results: Post-treatment results of both tests revealed that patients in group 1 achieved lower mean total scores than group 2. In MoCA test, the deficits were especially prominent in the areas of language ability and short-term memory capacity (P < .05 and P < .05). No significant differences could be identified between groups in respect to attention, executive functions, visuospatial abilities, abstract thinking, calculating abilities, and orientation. In FAB test, the deficits were especially prominent in the areas of mental flexibility and inhibitory control (P < .05 and P < .05). No significant differences could be identified between groups in conceptualization, motor series, conflicting instructions, and environmental autonomy.
Conclusion: ADT affects cognitive functions such as language ability, short-term memory capacity, mental flexibility, and inhibitory control. Urologists should keep in mind these side effects and inform the patients and their families for the early symptoms of cognitive dysfunction.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment in
-
Editorial Comment.Urology. 2017 May;103:171-172. doi: 10.1016/j.urology.2016.12.061. Epub 2017 Mar 2. Urology. 2017. PMID: 28262336 No abstract available.
-
Re: Gunlusoy et al.: Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer: Methodological Issues (Urology 2017;103:167-172).Urology. 2017 Jun;104:244. doi: 10.1016/j.urology.2017.02.041. Epub 2017 Mar 16. Urology. 2017. PMID: 28315784 No abstract available.
Similar articles
-
The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study.Aging Male. 2020 Dec;23(5):733-739. doi: 10.1080/13685538.2019.1586869. Epub 2019 Mar 29. Aging Male. 2020. PMID: 30924381
-
The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.Psychooncology. 2020 Aug;29(8):1338-1346. doi: 10.1002/pon.5442. Epub 2020 Jul 2. Psychooncology. 2020. PMID: 32539186
-
Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.Eur J Cancer Care (Engl). 2015 Mar;24(2):198-204. doi: 10.1111/ecc.12299. Eur J Cancer Care (Engl). 2015. PMID: 25711542
-
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.Support Care Cancer. 2014 Aug;22(8):2271-80. doi: 10.1007/s00520-014-2285-1. Epub 2014 May 25. Support Care Cancer. 2014. PMID: 24859915 Free PMC article. Review.
-
Locally advanced prostate cancer: effective treatments, but many adverse effects.Prescrire Int. 2013 Jan;22(134):18-20, 22-3. Prescrire Int. 2013. PMID: 23367679 Review.
Cited by
-
Psychosocial Factors Associated with Cognitive Function in Prostate Cancer Survivors on Hormonal Treatments: A Systematic Review.Neuropsychol Rev. 2024 Apr 20. doi: 10.1007/s11065-024-09639-1. Online ahead of print. Neuropsychol Rev. 2024. PMID: 38642173 Review.
-
Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.Trials. 2024 Apr 12;25(1):257. doi: 10.1186/s13063-024-07989-y. Trials. 2024. PMID: 38610058 Free PMC article.
-
Coping strategies mediate the relationship between fear of cancer recurrence and quality of life in postoperative patients with prostate cancer: a multicentre survey.BMC Urol. 2024 Mar 1;24(1):49. doi: 10.1186/s12894-024-01428-5. BMC Urol. 2024. PMID: 38429701 Free PMC article.
-
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077. Medicina (Kaunas). 2023. PMID: 38256338 Free PMC article. Review.
-
A review of the objective cognitive function measurements in males receiving hormonal therapy for prostate cancer.Investig Clin Urol. 2023 Nov;64(6):521-540. doi: 10.4111/icu.20230103. Investig Clin Urol. 2023. PMID: 37932563 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous